Obesogens: Definition, mechanisms of action, potential industrial chemicals and pharmaceuticals

Yıl 2022, , 215 - 225, 30.08.2022

Bıta Entezarı , Deniz Bozdağ Hande Gürer-orhan

https://doi.org/10.26650/IstanbulJPharm.2022.1027027

Öz

The incidence of obesity and related diseases increased dramatically in the last decade. Some endocrine disruptors were shown to interact with metabolic processes via various cellular mechanisms, disrupt homeostasis in adipose tissue, resulting in weight gain and obesity. These chemicals are called “obesogens”. Today, with the increased use of industrial chemicals, individuals are exposed to a mixture of chemicals at very low doses. Most of these industrial chemicals have been investigated for their possible endocrine disrupting and obesogenic effects. Beside these chemicals, pharmaceuticals can also have similar adverse effects, however, limited studies have been performed to investigate such effects of drugs. Furthermore, there are few studies investigating the relationship between prenatal exposure to pharmaceuticals and childhood obesity. Therefore, to clarify the endocrine disrupting and obesogenic effects of the pharmaceuticals, which are prescribed during pregnancy, mechanistic studies should be performed, and necessary precautions should be taken. In this paper, we reviewed the mechanisms of obesogens, briefly overview several well-known obesogenic industrial chemicals and focused more on potential obesogenic pharmaceuticals.

Anahtar Kelimeler

Endocrine disruptors, Obesogens, Adipogenesis, Lipogenesis, Pharmaceuticals

Destekleyen Kurum

EGE ÜNİVERSİTESİ BAP Koordinatörlüğü

Proje Numarası

TDK-2020-21680

Teşekkür

Authors are thankful to Ege University Scientific Research Projects Coordination for supporting doctoral research of Bita ENTEZARI with the grant ID # TDK-2020-21680

Kaynakça

• Ahmed, S., & Atlas, E. (2016). Bisphenol S- and bisphenol A-in- duced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma acti- vation. International Journal of Obesity (2005), 40(10), 1566–1573. https://doi.org/10.1038/IJO.2016.95
• Albaugh, V. L., Judson, J. G., She, P., Lang, C. H., Maresca, K. P., Joyal, J. L., & Lynch, C. J. (2011). Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Mo- lecular Psychiatry, 16(5), 569–581. https://doi.org/10.1038/MP.2010.33
• Albert, O., Desdoits-Lethimonier, C., Lesné, L., Legrand, A., Guillé, F., Bensalah, K., … Jégou, B. (2013). Paracetamol, aspirin and in- domethacin display endocrine disrupting properties in the adult human testis in vitro. Human Reproduction (Oxford, England), 28(7), 1890–1898. https://doi.org/10.1093/humrep/det112
• Alonso-Magdalena, P., Laribi, O., Ropero, A. B., Fuentes, E., Ripoll, C., Soria, B., & Nadal, A. (2005). Low doses of bisphenol A and di- ethylstilbestrol impair Ca2+ signals in pancreatic α-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environmental Health Perspectives, 113(8), 969–977. https://doi.org/10.1289/ehp.8002
• Arterburn, D., Sofer, T., Boudreau, D., Bogart, A., Westbrook, E., Theis, M., … Haneuse, S. (2016). Long-Term Weight Change after Initiating Second-Generation Antidepressants. Journal of Clinical Medicine, 5(4), 48-60. https://doi.org/10.3390/jcm5040048
• Atli, O., Baysal, M., Aydogan-Kilic, G., Kilic, V., Ucarcan, S., Kara- duman, B., & Ilgin, S. (2017). Sertraline-induced reproductive toxicity in male rats: Evaluation of possible underlying mecha- nisms. Asian Journal of Andrology, 19(6), 672–679. https://doi. org/10.4103/1008-682X.192637
• Autrup, H., Barile, F. A., Berry, S. C., Blaauboer, B. J., Boobis, A., Bolt, H., … Vermeulen, N. P. (2020). Human exposure to synthetic en- docrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable en- docrine activity. How to evaluate the risk of the S-EDCs? Toxicol- ogy in Vitro, 67, 104861. https://doi.org/10.1016/J.TIV.2020.104861
• Baillie-Hamilton, P. F. (2002). Chemical toxins: A hypothesis to explain the global obesity epidemic. Journal of Alterna- tive and Complementary Medicine, 8(2), 185–192. https://doi. org/10.1089/107555302317371479
• Bashshur, R. L., Mandil, S. H., & Shannon, G. W. (2002). Global as- sessment of the state-of-the-science of endocrine disruptors - Chapter 1: Executive summary. Telemedicine Journal and E-Health, 8(1), 95–107. https://doi.org/10.1089/15305620252933437
• Bastos Sales, L., Kamstra, J. H., Cenijn, P. H., van Rijt, L. S., Hamers, T., & Legler, J. (2013). Effects of endocrine disrupting chemicals on in vitro global DNA methylation and adipocyte differentiation. Toxicology in Vitro, 27(6), 1634–1643. https://doi.org/10.1016/J. TIV.2013.04.005
• Blumenthal, S. R., Castro, V. M., Clements, C. C., Rosenfield, H. R., Murphy, S. N., Fava, M., … Perlis, R. H. (2014). An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry, 71(8), 889–896. https://doi.org/10.1001/ja- mapsychiatry.2014.414
• Buck Louis, G. M., Chen, Z., Kim, S., Smarr, M. M., & Kannan, K. (2017). Male urinary paracetamol and semen quality. Andrology, 5(6), 1082–1088. https://doi.org/10.1111/andr.12413
• Casals-Casas, C., & Desvergne, B. (2011). Endocrine Disruptors: From Endocrine to Metabolic Disruption. Annual Review of Physi- ology, 73(1), 135–162. https://doi.org/10.1146/annurev-physi- ol-012110-142200
• Chamorro-Garcia, R., Diaz-Castillo, C., Shoucri, B. M., Käch, H., Leavitt, R., Shioda, T., & Blumberg, B. (2017). Ancestral perina- tal obesogen exposure results in a transgenerational thrifty phenotype in mice. Nature Communications, 8(1). https://doi. org/10.1038/s41467-017-01944-z
• Chamorro-García, R., Sahu, M., Abbey, R. J., Laude, J., Pham, N., & Blumberg, B. (2013). Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environmental Health Perspectives, 121(3), 359–366. https://doi. org/10.1289/ehp.1205701
• Chawla, S., Kaushik, N., Singh, N. P., Ghosh, R. K., & Saxena, A. (2013). Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metfor- min: A randomized controlled trial. Journal of Pharmacology and Pharmacotherapeutics, 4(1), 27–32. https://doi.org/10.4103/0976- 500X.107656
• Chu, D. T., Malinowska, E., Jura, M., & Kozak, L. P. (2017). C57BL/6J mice as a polygenic developmental model of diet-induced obesity. Physi- ological Reports, 5(7), e13093. https://doi.org/10.14814/phy2.13093
• Cohen, I. C., Cohenour, E. R., Harnett, K. G., & Schuh, S. M. (2021). BPA, BPAF and TMBPF Alter Adipogenesis and Fat Accumulation in Human Mesenchymal Stem Cells, with Implications for Obesi- ty. International Journal of Molecular Sciences, 22(10), 5363. https:// doi.org/10.3390/ijms22105363
• Darbre, P. D. (2017). Endocrine Disruptors and Obesity. Current Obesity Reports, 6(1), 18–27. https://doi.org/10.1007/s13679-017-0240-4
• Davis, K. E., Carstens, E. J., Irani, B. G., Gent, L. M., Hahner, L. M., & Clegg, D. J. (2014). Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis. Hormones and Behavior, Vol. 66, pp. 196–207. Academic Press Inc. https://doi.org/10.1016/j.yhbeh.2014.02.004
• De Cock, M., & Van de Bor, M. (2014). Obesogenic effects of endocrine disruptors, what do we know from animal and hu- man studies? Environment International, 70, 15–24. https://doi. org/10.1016/j.envint.2014.04.022
• Feige, J. N., Gelman, L., Rossi, D., Zoete, V., Métivier, R., Tudor, C.,… Desvergne, B. (2007). The endocrine disruptor monoethyl- hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. The Journal of Biological Chemistry, 282(26), 19152–19166. https://doi. org/10.1074/JBC.M702724200
• Foley, B., Clewell, R., & Deisenroth, C. (2015). Development of a Human Adipose-Derived Stem Cell Model for Characterization of Chemical Modulation of Adipogenesis. Applied In Vitro Toxicology, 1(1), 66–78. https://doi.org/10.1089/aivt.2014.0007
• Fürnsinn, C., & Waldhäusl, W. (2002). Thiazolidinediones: Meta- bolic actions in vitro. Diabetologia, Vol. 45, pp. 1211–1223. https:// doi.org/10.1007/s00125-002-0899-1
• Gafoor, R., Booth, H. P., & Gulliford, M. C. (2018). Antidepressant utilisation and incidence of weight gain during 10 years’ follow- up: Population based cohort study. BMJ (Online), 361. https://doi. org/10.1136/bmj.k1951
• Greenberg, E. R., Barnes, A. B., Resseguie, L., Barrett, J. A., Burn- side, S., Lanza, L. L., … Colton, T. (1984). Breast Cancer in Moth- ers Given Diethylstilbestrol in Pregnancy. New England Jour- nal of Medicine, 311(22), 1393–1398. https://doi.org/10.1056/ nejm198411293112201
• Gregorian Jr, R. S., Golden, K. A., Bahce, A., Goodman, C., & Kwong, W. J. (2002). Antidepressant-Induced Sexual Dysfunction. The Annals of pharmacotherapy, 36(10), 1577–1589. https://doi. org/10.1345/aph.1A195.
• Griffin, M. D., Pereira, S. R., DeBari, M. K., & Abbott, R. D. (2020). Mechanisms of action, chemical characteristics, and model systems of obesogens. BMC Biomedical Engineering, 2(1), 1–13. https://doi.org/10.1186/s42490-020-00040-6
• Grün, F., & Blumberg, B. (2006a). Environmental obesogens: Or- ganotins and endocrine disruption via nuclear receptor signaling. Endocrinology, Vol. 147. https://doi.org/10.1210/en.2005-1129
• Grün, F., Watanabe, H., Zamanian, Z., Maeda, L., Arima, K., Cubacha, R., … Blumberg, B. (2006b). Endocrine-disrupting organotin com- pounds are potent inducers of adipogenesis in vertebrates. Mo- lecular Endocrinology, 20(9), 2141–2155. https://doi.org/10.1210/ me.2005-0367
• Gupta, R., Kumar, P., Fahmi, N., Garg, B., Dutta, S., Sachar, S., … Vimaleswaran, K. S. (2020). Endocrine disruption and obesity: A current review on environmental obesogens. Current Research in Green and Sustainable Chemistry, 3. https://doi.org/10.1016/J. CRGSC.2020.06.002
• Haliakon, S., Doare, L., Foufelle, F., Kergoat, M., Guerre-Millo, M., Berthault, M.-F., … Ferre, P. (1997). Pioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat. Diabetes, 46(9), 1393–1399. https://doi.org/10.2337/diab.46.9.1393
• Hansen, C. H., Larsen, L. W., Sørensen, A. M., Halling-Sørensen, B., & Styrishave, B. (2017). The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line. Toxicology in Vitro, 41, 1–11. https://doi. org/10.1016/j.tiv.2017.02.001
• Hao, C., Cheng, X., Guo, J., Xia, H., & Ma, X. (2013). Perinatal exposure to diethyl-hexyl-phthalate induces obesity in mice. Frontiers in Bio- science (Elite Edition), 5(2), 725–733. https://doi.org/10.2741/E653
• Hao, C. J., Cheng, X. J., Xia, H. F., & Ma, X. (2012a). The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice. Toxicology and Applied Pharmacology, 263(1), 102–110. https://doi.org/10.1016/j.taap.2012.06.003
• Hao, C. J., Cheng, X. J., Xia, H. F., & Ma, X. (2012b). The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice. Toxicology and Applied Pharmacology, 263(1), 102–110. https://doi.org/10.1016/j.taap.2012.06.003
• Hatch, E. E., Troisi, R., Palmer, J. R., Wise, L. A., Titus, L., Strohsnitter, W. C., … Hoover, R. N. (2014). Prenatal diethylstilbestrol exposure and risk of obesity in adult women. Journal of Developmental Ori- gins of Health and Disease, 6(3), 201–207. https://doi.org/10.1017/ S2040174415000033
• Hausman, G. J., Poulos, S. P., Pringle, T. D., & Azain, M. J. (2008). The influence of thiazolidinediones on adipogenesis in vitro and in vivo: potential modifiers of intramuscular adipose tissue deposi- tion in meat animals. Journal of Animal Science, Vol. 86. https://doi. org/10.2527/jas.2007-0219
• Heitzer, M. D., Wolf, I. M., Sanchez, E. R., Witchel, S. F., & DeFran- co, D. B. (2007). Glucocorticoid receptor physiology. Reviews in Endocrine and Metabolic Disorders, Vol. 8, pp. 321–330. Springer. https://doi.org/10.1007/s11154-007-9059-8
• Hill, J. O., Wyatt, H. R., & Peters, J. C. (2012). Energy balance and obesity. Circulation, 126(1), 126–132. https://doi.org/10.1161/CIR- CULATIONAHA.111.087213
• Homma, H., Kurachi, H., Nishio, Y., Takeda, T., Yamamoto, T., Adachi, K., … Murata, Y. (2000). Estrogen suppresses transcription of lipopro- tein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. Journal of Biological Chemistry, 275(15), 11404–11411. https://doi.org/10.1074/jbc.275.15.11404
• Hoover, R. N., Hyer, M., Pfeiffer, R. M., Adam, E., Bond, B., Cheville, A. L., … Troisi, R. (2011). Adverse Health Outcomes in Women Ex- posed In Utero to Diethylstilbestrol. New England Journal of Medi- cine, 365(14), 1304–1314. https://doi.org/10.1056/nejmoa1013961
• Jacobsen, N. W., Hansen, C. H., Nellemann, C., Styrishave, B., & Hal- ling-Sørensen, B. (2015). Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. Toxicology in Vitro, 29(7), 1729–1735. https://doi.org/10.1016/j.tiv.2015.07.005
• Janesick, A., & Blumberg, B. (2012). Obesogens, stem cells and the developmental programming of obesity. International Journal of Andrology, Vol. 35, pp. 437–448. NIH Public Access. https://doi. org/10.1111/j.1365-2605.2012.01247.x
• Janesick, A. S., Dimastrogiovanni, G., Vanek, L., Boulos, C., Cham- orro-García, R., Tang, W., & Blumberg, B. (2016). On the utility of ToxCastTM and ToxPi as methods for identifying new obesogens. Environmental Health Perspectives, 124(8), 1214–1226. https://doi. org/10.1289/ehp.1510352
• Janesick, Amanda, & Blumberg, B. (2011). Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Research Part C: Embryo Today: Reviews, 93(1), 34–50. https://doi.org/10.1002/BDRC.20197
• Jensen, E. T., & Longnecker, M. P. (2014). Pharmacologic sex hor- mones in pregnancy in relation to offspring obesity. Obesity, 22(11), 2406–2412. https://doi.org/10.1002/oby.20778
• Kanayama, T., Kobayashi, N., Mamiya, S., Nakanishi, T., & Nishikawa,
• J. I. (2005). Organotin compounds promote adipocyte differentia- tion as agonists of the peroxisome proliferator-activated recep- tor γ/retinoid X receptor pathway. Molecular Pharmacology, 67(3), 766–774. https://doi.org/10.1124/mol.104.008409
• Kersten, S. (2001). Mechanisms of nutritional and hormonal regu- lation of lipogenesis. EMBO Reports, 2(4), 282–286. https://doi. org/10.1093/embo-reports/kve071
• Kirchner, S., Kieu, T., Chow, C., Casey, S., & Blumberg, B. (2010). Pre- natal exposure to the environmental obesogen tributyltin predis- poses multipotent stem cells to become adipocytes. Molecular En- docrinology, 24(3), 526–539. https://doi.org/10.1210/me.2009-0261
• Koya, D., & Kanasaki, K. (2011). Biology of obesity: Lessons from animal models of obesity. Journal of Biomedicine and Biotechnol- ogy, Vol. 2011. https://doi.org/10.1155/2011/197636
• La Merrill, M. A., Vandenberg, L. N., Smith, M. T., Goodson, W., Browne, P., Patisaul, H. B., … Zoeller, R. T. (2020). Consensus on the key characteristics of endocrine-disrupting chemicals as a ba- sis for hazard identification. Nature Reviews Endocrinology, 16(1), 45–57. https://doi.org/10.1038/s41574-019-0273-8
• La Merrill, M., & Birnbaum, L. S. (2011). Childhood obesity and environmental chemicals. Mount Sinai Journal of Medicine, 78(1), 22–48. https://doi.org/10.1002/msj.20229
• Lebovitz, H. E. (2019). Thiazolidinediones: the Forgotten Diabetes Medications. Current Diabetes Reports, Vol. 19, pp. 1–13. Springer. https://doi.org/10.1007/s11892-019-1270-y
• Lefterova, M. I., & Lazar, M. A. (2009). New developments in adipo- genesis. Trends in Endocrinology and Metabolism, 20(3), 107–114. https://doi.org/10.1016/j.tem.2008.11.005
• Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Will- son, T. M., & Kliewer, S. A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated re- ceptor γ (PPARγ). Journal of Biological Chemistry, 270(22), 12953– 12956. https://doi.org/10.1074/jbc.270.22.12953
• Li, X., Ycaza, J., & Blumberg, B. (2011). The environmental obeso- gen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 pre- adipocytes. Journal of Steroid Biochemistry and Molecular Biology, 127(1–2), 9–15. https://doi.org/10.1016/j.jsbmb.2011.03.012
• Liew, Z., Nohr, E. A., Morgen, C. S., Ernst, A., Li, J., Sørensen, T. I. A., & Olsen, J. (2019). Prenatal Exposure to Acetaminophen and Overweight in Childhood. Obesity, 27(8), 1314–1322. https://doi. org/10.1002/oby.22526
• Lind, D. V., Main, K. M., Kyhl, H. B., Kristensen, D. M., Toppari, J., An- dersen, H. R., … Jensen, T. K. (2017). Maternal use of mild analgesics during pregnancy associated with reduced anogenital distance in sons: A cohort study of 1027 mother-child pairs. Human Reproduc- tion, 32(1), 223–231. https://doi.org/10.1093/humrep/dew285
• Lord, C. C., Wyler, S. C., Wan, R., Castorena, C. M., Ahmed, N., Mathew, D., … Elmquist, J. K. (2017). Atypical antipsychotic causes weight gain by targeting serotonin receptor 2C. Clinical Pharma- cist, 9(10), 3402–3406. https://doi.org/10.1211/CP.2017.20203665
• MacKay, H., & Abizaid, A. (2018). A plurality of molecular targets: The receptor ecosystem for bisphenol-A (BPA). Hormones and Behavior, 101(November), 59–67. https://doi.org/10.1016/j.yh- beh.2017.11.001
• Maloney, E. K., & Waxman, D. J. (1999). trans-Activation of PPA- Ralpha and PPARgamma by structurally diverse environmental chemicals. Toxicology and Applied Pharmacology, 161(2), 209–218. https://doi.org/10.1006/TAAP.1999.8809
• Manikkam, M., Tracey, R., Guerrero-Bosagna, C., & Skinner, M. K. (2013). Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. PloS One, 8(1). https://doi.org/10.1371/JOURNAL.PONE.0055387
• Masuno, H., Kidani, T., Sekiya, K., Sakayama, K., Shiosaka, T., Yama- moto, H., & Honda, K. (2002). Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. Journal of Lipid Research, 43(5), 676–684. https://doi. org/10.1016/S0022-2275(20)30108-5
• Mauvais-Jarvis, F. (2011). Estrogen and androgen receptors: Regu- lators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab, 22(1), 24–33. https://doi. org/10.1016/j.tem.2010.10.002
• McTernan, P. G., Harte, A. L., Anderson, L. A., Green, A., Smith, S. A., Holder, J. C., … Kumar, S. (2002). Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes, 51(5), 1493–1498. https://doi.org/10.2337/dia- betes.51.5.1493
• Miettinen, S., Sarkanen, J. R., & Ashammakhi, N. (2008). Adipose Tissue and Adipocyte Differentiation: Molecular and Cellular As- pects and Tissue Engineering Applications. Topics in Tissue Engi- neering, 4, 1–26.
• Moazzam, S., Jarmasz, J. S., Jin, Y., Siddiqui, T. J., & Cattini, P. A. (2021). Effects of high fat diet-induced obesity and pregnancy on prepartum and postpartum maternal mouse behavior. Psy- choneuroendocrinology, 126, 105147. https://doi.org/10.1016/j. psyneuen.2021.105147
• Montagnini, B. G., Bortolan, S., Santos, B. D. Dos, Moreno, A. P., De Azevedo Camin, N., Gerardin, D. C. C., & Moreira, E. G. (2013). Eval- uation of escitalopram, sertraline, and methylphenidate in the immature rat uterotrophic assay. International Journal of Toxicol- ogy, 32(6), 426–430. https://doi.org/10.1177/1091581813509674
• Moraitis, A. G., Block, T., Nguyen, D., & Belanoff, J. K. (2017, Janu- ary 1). The role of glucocorticoid receptors in metabolic syn- drome and psychiatric illness. Journal of Steroid Biochemistry and Molecular Biology, Vol. 165, pp. 114–120. Elsevier Ltd. https://doi. org/10.1016/j.jsbmb.2016.03.023
• Mori, Y., Murakawa, Y., Okada, K., Horikoshi, H., Yokoyama, J., Ta- jima, N., & Ikeda, Y. (1999). Effect of troglitazone on body fat distri- bution in type 2 diabetic patients. Diabetes Care, 22(6), 908–912. https://doi.org/10.2337/diacare.22.6.908
• Moseti, D., Regassa, A., & Kim, W. K. (2016). Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules. International Journal of Molecular Sciences, 17(1), 1–24. https://doi. org/10.3390/ijms17010124
• Müller, J. C., Imazaki, P. H., Boareto, A. C., Lourenço, E. L. B., Golin, M., Vechi, M. F., … Dalsenter, P. R. (2012). In vivo and in vitro estrogen- ic activity of the antidepressant fluoxetine. Reproductive Toxicol- ogy, 34(1), 80–85. https://doi.org/10.1016/j.reprotox.2012.04.001
• Munkboel, C. H., Larsen, L. W., Weisser, J. J., Kristensen, D. M., & Styrishave, B. (2018). Sertraline suppresses testis and adrenal steroid production and steroidogenic gene expression while increasing LH in Plasma of male rats resulting in compensatory hypogonadism. Toxicological Sciences, 163(2), 609–619. https:// doi.org/10.1093/toxsci/kfy059
• Murphy, R., Stewart, A. W., Braithwaite, I., Beasley, R., Hancox, R. J., & Mitchell, E. A. (2015). Association between paracetamol use in infancy or childhood with body mass index. Obesity, 23(5), 1030– 1038. https://doi.org/10.1002/oby.21045
• Newbold, R. R., Padilla-Banks, E., Jefferson, W. N., & Heindel, J. J. (2008). Effects of endocrine disruptors on obesity. International Journal of Andrology, 31(2), 201–207. https://doi.org/10.1111/ j.1365-2605.2007.00858.x
• Newbold, R. R., Padilla-banks, E., Snyder, R. J., & Jefferson, W. N. (2005). Developmental Exposure to Estrogenic Compounds and Obesity. 480, 478–480. https://doi.org/10.1002/bdra.20147
• Newbold, R. R., Padilla-Banks, E., Snyder, R. J., & Jefferson, W. N. (2007a). Perinatal exposure to environmental estrogens and the development of obesity. Molecular Nutrition and Food Research, Vol. 51, pp. 912–917. https://doi.org/10.1002/mnfr.200600259
• Newbold, R. R., Padilla-Banks, E., Snyder, R. J., Phillips, T. M., & Jef- ferson, W. N. (2007b). Developmental exposure to endocrine dis- ruptors and the obesity epidemic. Reproductive Toxicology, Vol. 23, pp. 290–296. https://doi.org/10.1016/j.reprotox.2006.12.010
• Obri, A., Serra, D., Herrero, L., & Mera, P. (2020). The role of epi- genetics in the development of obesity. Biochemical Pharmacol- ogy, Vol. 177, p. 113973. Elsevier Inc. https://doi.org/10.1016/j. bcp.2020.113973
• OECD. (2012). OECD Detailed review paper on the state of the science on novel in vitro and in vivo screening and testing methods and endpoints for evaluating endocrine disruptors OECD Environment, Health and Safety Publica- tions Series on Testing and Assessment 2012 Par. Retrieved November 6, 2021, from https://www.oecd-ilibrary.org/ docserver/9789264221352-en.pdf?expires=1636196089&id=i d&accname=guest&checksum=960E616120F388C1D44E902 319C840AC
• Palin, S. L., McTernan, P. G., Anderson, L. A., Sturdee, D. W., Bar- nett, A. H., & Kumar, S. (2003). 17β-Estradiol and anti-estrogen ICI:compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdomi- nal adipocytes. Metabolism: Clinical and Experimental, 52(4), 383–388. https://doi.org/10.1053/meta.2003.50088
• Palmer, J. R., Herbst, A. L., Noller, K. L., Boggs, D. A., Troisi, R., Titus- Ernstoff, L., … Hoover, R. N. (2009). Urogenital abnormalities in men exposed to diethylstilbestrol in utero: A cohort study. Envi- ronmental Health: A Global Access Science Source, 8, 37. https://doi. org/10.1186/1476-069X-8-37
• Pedersen, S. B., Børglum, J. D., Mø11er-Pedersen, T., & Richelsen, B. (1992). Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Molecular and Cellular Endocrinology, 85(1–2), 13–19. https://doi.org/10.1016/0303-7207(92)90120-U
• Peeke, P. M., & Chrousos, G. P. (1995). Hypercortisolism and Obe- sity. Annals of the New York Academy of Sciences, 771(1), 665–676. https://doi.org/10.1111/j.1749-6632.1995.tb44719.x
• Piersma, A. H., Luijten, M., Popov, V., Tomenko, V., Altstein, M., Kagampang, F., & Schlesinger, H. (2009). Pharmaceuticals. In En- docrine-Disrupting Chemicals in Food (pp. 459–518). Elsevier Ltd. https://doi.org/10.1533/9781845695743.4.459
• Raeder, M. B., Fernø, J., Vik-Mo, A. O., & Steen, V. M. (2006). SREBP activation by antipsychotic- and antidepressant-drugs in cul- tured human liver cells: Relevance for metabolic side-effects? Molecular and Cellular Biochemistry, 289(1–2), 167–173. https:// doi.org/10.1007/s11010-006-9160-4
• Rask, E., Olsson, T., Söderberg, S., Andrew, R., Livingstone, D. E. W., Johnson, O., & Walker, B. R. (2001). Tissue-specific dysregula- tion of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism, 86(3), 1418–1421. https://doi. org/10.1210/jcem.86.3.7453
• Richard, A. J., White, U., Elks, C. M., & Stephens, J. M. (2000). Adi- pose Tissue: Physiology to Metabolic Dysfunction. In Endotext. MDText.com, Inc. Retrieved from http://www.ncbi.nlm.nih.gov/ pubmed/32255578
• Rissman, E. F., & Adli, M. (2014). Minireview: Transgenerational Epi- genetic Inheritance: Focus on Endocrine Disrupting Compounds. Endocrinology, 155(8), 2770. https://doi.org/10.1210/EN.2014-1123
• Ritchie, H., & Max, R. (2017). Obesity - Our World in Data. Retrieved November 4, 2021, from https://ourworldindata.org/obesity
• Romao, J. M., & Guan, L. L. (2014). Adipogenesis and Obesity. In MicroRNA in Regenerative Medicine (pp. 539–565). Elsevier Inc. https://doi.org/10.1016/B978-0-12-405544-5.00021-6
• Rönn, M., Lind, L., Örberg, J., Kullberg, J., Söderberg, S., Larsson, A., … Lind, P. M. (2014). Bisphenol A is related to circulating lev- els of adiponectin, leptin and ghrelin, but not to fat mass or fat distribution in humans. Chemosphere, 112, 42–48. https://doi. org/10.1016/J.CHEMOSPHERE.2014.03.042
• Rosen, E. D., & MacDougald, O. A. (2006). Adipocyte differentiation from the inside out. Nature Reviews Molecular Cell Biology, 7(12), 885–896. https://doi.org/10.1038/nrm2066
• Rubin, B. S., Paranjpe, M., DaFonte, T., Schaeberle, C., Soto, A. M., Obin, M., & Greenberg, A. S. (2017). Perinatal BPA exposure alters body weight and composition in a dose specific and sex specific manner: The addition of peripubertal exposure exacerbates ad- verse effects in female mice. Reproductive Toxicology (Elmsford, N.Y.), 68, 130–144. https://doi.org/10.1016/J.REPROTOX.2016.07.020
• Safarinejad, M. R. (2008). Evaluation of endocrine profile and hypothalamic-pituitary-testis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction. Journal of Clinical Psychopharmacology, 28(4), 418–423. https://doi.org/10.1097/ JCP.0b013e31817e6f80
• Sarjeant, K., & Stephens, J. M. (2012). Adipogenesis. Cold Spring Harbor Perspectives in Biology, 4(9), a008417. https://doi.org/10.1101/cshperspect.a008417
• Schrager, S., & Potter, B. E. (2004). Diethylstilbestrol Exposure - Amer- ican Family Physician. Retrieved from www.aafp.org/afp.
• Sharma, G., Hu, C., Brigman, J. L., Zhu, G., Hathaway, H. J., & Prossnitz, E. R. (2013). GPER deficiency in male mice results in in- sulin resistance, dyslipidemia, and a proinflammatory state. Endo- crinology, 154(11), 4136–4145. https://doi.org/10.1210/en.2013-1357
• Sharma, G., & Prossnitz, E. R. (2017). G-protein-coupled estro- gen receptor (GPER) and sex-specific metabolic homeostasis. In Advances in Experimental Medicine and Biology. 1043, 427–453. https://doi.org/10.1007/978-3-319-70178-3_20
• Sharma, G., & Prossnitz, E. R. (2021). Targeting the G protein-cou- pled estrogen receptor (GPER) in obesity and diabetes. Endocrine and Metabolic Science, 2, 100080. https://doi.org/10.1016/j.end- mts.2021.100080
• Somm, E., Schwitzgebel, V. M., Toulotte, A., Cederroth, C. R., Combescure, C., Nef, S., … Hüppi, P. S. (2009). Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environmental Health Perspectives, 117(10), 1549–1555. https://doi.org/10.1289/ehp.11342
• Stahlhut, R. W., Wijngaarden, E. van, Dye, T. D., Stephen, C., & Swan,
• S. H. (2007). Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environmental Health Perspectives, 115(6), 876–882. https://doi.org/10.1289/EHP.9882
• Stel, J., & Legler, J. (2015). The role of epigenetics in the latent effects of early life exposure to obesogenic endocrine disrupt- ing chemicals. Endocrinology, 156(10), 3466–3472. https://doi. org/10.1210/EN.2015-1434
• Stger, R. (2008). Epigenetics and obesity. Pharmacogenomics, Vol. 9, pp. 1851–1860. https://doi.org/10.2217/14622416.9.12.1851
• Tafuri, S. R. (1996). Troglitazone Enhances Differentiation, Basal Glucose Uptake, and Glut1 Protein Levels in 3T3-Ll Adipo- cytes. Retrieved from https://academic.oup.com/endo/arti- cle/137/11/4706/2499032
• USEPA. (2021). What is the Endocrine System? | US EPA. Retrieved November 6, 2021, from https://www.epa.gov/endocrine-dis- ruption/what-endocrine-system
• Verhaegen, A. A., & Van Gaal, L. F. (2017). Drug-induced obesity and its metabolic consequences: a review with a focus on mech- anisms and possible therapeutic options. Journal of Endocrino- logical Investigation, 40(11), 1165–1174. https://doi.org/10.1007/ s40618-017-0719-6
• Vernon, R. G., & David J. Flint. (2011). Adipose tissue. Journal Fur Asthetische Chirurgie, 4(1), 28–34. https://doi.org/10.1007/s12631- 010-0116-x
• Wake, D. J., Rask, E., Livingstone, D. E. W., So¨derberg, S., So¨derberg, S., Olsson, T., & Walker, B. R. (2003). COMMENT Local and Systemic Impact of Transcriptional Up-Regulation of 11-Hydroxysteroid Dehy- drogenase Type 1 in Adipose Tissue in Human Obesity. https://doi. org/10.1210/jc.2003-030286
• WHO. (2021). WHO. Retrieved May 15, 2021, from World Health Organization website: https://www.who.int/news-room/fact- sheets/detail/obesity-and-overweight
• Wu, Z., Bucher, N. L., & Farmer, S. R. (1996). Induction of peroxi- some proliferator-activated receptor gamma during the conver- sion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Molecular and Cellular Biology, 16(8), 4128–4136. https://doi.org/10.1128/mcb.16.8.4128
• Yang, C., Lee, H. K., Kong, A. P. S., Lim, L. L., Cai, Z., & Chung, A. C. K. (2018). Early-life exposure to endocrine disrupting chemicals as- sociates with childhood obesity. Annals of Pediatric Endocrinology and Metabolism, Vol. 23, pp. 182–195. Korean society of pediatric endocrinology. https://doi.org/10.6065/apem.2018.23.4.182
• Yang, L.-H., Chen, T.-M., Yu, S.-T., & Chen, Y.-H. (2007). Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells. Pharma- cological Research, 56(3), 202–208. https://doi.org/10.1016/J. PHRS.2007.05.007
• Zhu, P., Yuen, J. M. L., Sham, K. W. Y., & Cheng, C. H. K. (2013). GPER mediates the inhibitory actions of estrogen on adipogenesis in 3T3-L1 cells through perturbation of mitotic clonal expansion. General and Comparative Endocrinology, 193, 19–26. https://doi. org/10.1016/j.ygcen.2013.07.004